Global Pertussis Vaccine 麻豆原创 Growth 2025-2031

Publication ID:

LPI07251691

Publication Date:

July 2, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pertussis Vaccine market size is predicted to grow from US$ 5605 million in 2025 to US$ 6942 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71鈥�85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
The 鈥淧ertussis Vaccine Industry Forecast鈥� looks at past sales and reviews total world Pertussis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pertussis Vaccine sales for 2025 through 2031. With Pertussis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pertussis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pertussis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pertussis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pertussis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pertussis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pertussis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Whole-cell Vaccines
Acellular Vaccines
Segmentation by Application:
12 Months Below
12 Months Above
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pertussis Vaccine market?
What factors are driving Pertussis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pertussis Vaccine market opportunities vary by end market size?
How does Pertussis Vaccine break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pertussis Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pertussis Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pertussis Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Pertussis Vaccine Segment by Type
2.2.1 Whole-cell Vaccines
2.2.2 Acellular Vaccines
2.3 Pertussis Vaccine Sales by Type
2.3.1 Global Pertussis Vaccine Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Pertussis Vaccine Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Pertussis Vaccine Sale Price by Type (2020-2025)
2.4 Pertussis Vaccine Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 Pertussis Vaccine Sales by Application
2.5.1 Global Pertussis Vaccine Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Pertussis Vaccine Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Pertussis Vaccine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pertussis Vaccine Breakdown Data by Company
3.1.1 Global Pertussis Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Pertussis Vaccine Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Pertussis Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Pertussis Vaccine Revenue by Company (2020-2025)
3.2.2 Global Pertussis Vaccine Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Pertussis Vaccine Sale Price by Company
3.4 Key Manufacturers Pertussis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pertussis Vaccine Product Location Distribution
3.4.2 Players Pertussis Vaccine Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Pertussis Vaccine by Geographic Region
4.1 World Historic Pertussis Vaccine 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Pertussis Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pertussis Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pertussis Vaccine 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Pertussis Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pertussis Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pertussis Vaccine Sales Growth
4.4 APAC Pertussis Vaccine Sales Growth
4.5 Europe Pertussis Vaccine Sales Growth
4.6 Middle East & Africa Pertussis Vaccine Sales Growth
5 Americas
5.1 Americas Pertussis Vaccine Sales by Country
5.1.1 Americas Pertussis Vaccine Sales by Country (2020-2025)
5.1.2 Americas Pertussis Vaccine Revenue by Country (2020-2025)
5.2 Americas Pertussis Vaccine Sales by Type (2020-2025)
5.3 Americas Pertussis Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pertussis Vaccine Sales by Region
6.1.1 APAC Pertussis Vaccine Sales by Region (2020-2025)
6.1.2 APAC Pertussis Vaccine Revenue by Region (2020-2025)
6.2 APAC Pertussis Vaccine Sales by Type (2020-2025)
6.3 APAC Pertussis Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pertussis Vaccine by Country
7.1.1 Europe Pertussis Vaccine Sales by Country (2020-2025)
7.1.2 Europe Pertussis Vaccine Revenue by Country (2020-2025)
7.2 Europe Pertussis Vaccine Sales by Type (2020-2025)
7.3 Europe Pertussis Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pertussis Vaccine by Country
8.1.1 Middle East & Africa Pertussis Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pertussis Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pertussis Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Pertussis Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccine
10.3 Manufacturing Process Analysis of Pertussis Vaccine
10.4 Industry Chain Structure of Pertussis Vaccine
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pertussis Vaccine Distributors
11.3 Pertussis Vaccine Customer
12 World Forecast Review for Pertussis Vaccine by Geographic Region
12.1 Global Pertussis Vaccine 麻豆原创 Size Forecast by Region
12.1.1 Global Pertussis Vaccine Forecast by Region (2026-2031)
12.1.2 Global Pertussis Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pertussis Vaccine Forecast by Type (2026-2031)
12.7 Global Pertussis Vaccine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Pertussis Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pertussis Vaccine Product Portfolios and Specifications
13.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Walvax Biotechnology
13.5.1 Walvax Biotechnology Company Information
13.5.2 Walvax Biotechnology Pertussis Vaccine Product Portfolios and Specifications
13.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Walvax Biotechnology Main Business Overview
13.5.5 Walvax Biotechnology Latest Developments
13.6 Minhai Biotechnology
13.6.1 Minhai Biotechnology Company Information
13.6.2 Minhai Biotechnology Pertussis Vaccine Product Portfolios and Specifications
13.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Minhai Biotechnology Main Business Overview
13.6.5 Minhai Biotechnology Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Pertussis Vaccine Product Portfolios and Specifications
13.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 Chengdu Institute of Biological Products
13.8.1 Chengdu Institute of Biological Products Company Information
13.8.2 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolios and Specifications
13.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Chengdu Institute of Biological Products Main Business Overview
13.8.5 Chengdu Institute of Biological Products Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.